In this issue:
Induction and maintenance mirikizumab for UC
VTE risk stratification for IBD surgery
Second-line biologic and small molecules after TNF inhibitors in UC
IBD risk increased after broad-spectrum antibiotic exposure
Real-world use of tofacitinib for UC
PROMs and disability are associated with histological disease activity in UC
Restorative proctocolectomy ± defunctioning loop ileostomy for UC
Maintenance thioguanines for IBD
Correlations of ustekinumab tissue and serum concentrations in IBD
Infliximab concentrations and transmural sonographic healing in IBD
Please login below to download this issue (PDF)